TradingKey

關於 QuidelOrtho Corp 公司

QuidelOrtho Corporation 從事體外診斷、開發和製造智能解決方案。該公司通過直銷團隊和分銷商網絡將其產品直接銷售給最終用戶，供醫生辦公室、醫院、臨牀實驗室、參考實驗室、緊急護理診所、大學、零售診所、藥房、健康篩查中心、其他即時診斷 (POC) 場所、血庫和捐獻中心的專業使用，以及供個人、非專業、非處方 (OTC) 使用。該公司以各種品牌提供診斷測試解決方案，包括 AdenoPlus、BIOVUE、FreshCells、InflammaDry、Lyra、MeterPro、MicroVue、Ortho、Ortho Clinical Diagnostics、Ortho Connect、Ortho Plus、Ortho Vision、QuickVue、Quidel、QuidelOrtho、QVue、Savanna、Sofia、Solana、Thyretain、Triage、Virena、Vitros 等。它爲 130 多個國家和地區的客戶提供支持。

公司簡介

公司代碼QDEL

公司名稱QuidelOrtho Corp

上市日期Feb 01, 1991

CEOMr. Brian J. Blaser

員工數量6600

證券類型Ordinary Share

年結日Feb 01

公司地址9975 Summers Ridge Road

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編92121

電話18585521100

網址https://www.quidelortho.com/

公司代碼QDEL

上市日期Feb 01, 1991

CEOMr. Brian J. Blaser

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

11.45K

--

Mr. John R. Chiminski

Independent Director

2.52K

--

Sergio Gadaleta

Senior Vice President - Clinical and Regulatory Affairs

--

Devon Burek

Senior Vice President - Global Quality

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

地區USD

名稱

營收

佔比

North America

406.70M

58.70%

Other

122.20M

17.64%

EMEA

88.90M

12.83%

China

75.00M

10.83%

業務

地區

業務USD

名稱

營收

佔比

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

股東統計

更新時間: 6 小時前

持股股東

股東類型

持股股東

佔比

T. Rowe Price Investment Management, Inc.

16.86%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

AQR Capital Management, LLC

3.91%

Other

47.30%

持股股東

佔比

T. Rowe Price Investment Management, Inc.

16.86%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

AQR Capital Management, LLC

3.91%

Other

47.30%

股東類型

持股股東

佔比

Investment Advisor

60.15%

Investment Advisor/Hedge Fund

33.59%

Hedge Fund

15.15%

Research Firm

2.16%

Pension Fund

1.26%

Sovereign Wealth Fund

1.17%

Individual Investor

0.92%

Bank and Trust

0.69%

Private Equity

0.69%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

684

78.51M

115.63%

-21.42M

2025Q1

726

76.59M

113.26%

-21.60M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

2023Q1

894

68.68M

103.29%

-6.80M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

T. Rowe Price Investment Management, Inc.

11.45M

16.93%

+208.36K

+1.85%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.55M

11.17%

-233.81K

-3.00%

Mar 31, 2025

The Vanguard Group, Inc.

6.72M

9.94%

-77.05K

-1.13%

Mar 31, 2025

Rubric Capital Management LP

6.14M

9.08%

+590.00K

+10.63%

Mar 31, 2025

AQR Capital Management, LLC

2.66M

3.93%

+1.85M

+230.30%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.82M

2.69%

+600.34K

+49.32%

Mar 31, 2025

State Street Global Advisors (US)

2.19M

3.24%

-83.38K

-3.67%

Mar 31, 2025

American Century Investment Management, Inc.

1.59M

2.35%

+473.09K

+42.41%

Mar 31, 2025

ArrowMark Colorado Holdings, LLC

1.89M

2.8%

-84.96K

-4.30%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.15M

1.7%

+65.44K

+6.04%

Mar 31, 2025

持股ETF

更新時間: 8月6日週三

機構名稱

佔比

SPDR S&P Health Care Equipment ETF

1.7%

Invesco S&P SmallCap Health Care ETF

1.03%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.63%

Ballast Small/Mid Cap ETF

0.3%

SPDR S&P 600 Small Cap Value ETF

0.29%

Avantis US Small Cap Value ETF

0.28%

iShares S&P Small-Cap 600 Value ETF

0.24%

iShares U.S. Medical Devices ETF

0.22%

Avantis US Small Cap Equity ETF

0.21%

SPDR S&P SmallCap 600 ESG ETF

0.2%

SPDR S&P Health Care Equipment ETF

佔比1.7%

Invesco S&P SmallCap Health Care ETF

佔比1.03%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.63%

Ballast Small/Mid Cap ETF

佔比0.3%

SPDR S&P 600 Small Cap Value ETF

佔比0.29%

Avantis US Small Cap Value ETF

佔比0.28%

iShares S&P Small-Cap 600 Value ETF

佔比0.24%

iShares U.S. Medical Devices ETF

佔比0.22%

Avantis US Small Cap Equity ETF

佔比0.21%

SPDR S&P SmallCap 600 ESG ETF

佔比0.2%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

QuidelOrtho Corp

27.080USD

QuidelOrtho Corp

27.080

概覽

公司

財務